Voloridge Investment Management
CBAY

Voloridge Investment Management’s Cymabay Therapeutics CBAY Stock Holding History

Voloridge Investment Management’s Portfolio CBAY Stock Details CBAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-382,472
Closed -$4.19M – 1654
2023
Q2 		$4.19M Sell
382,472
-261,340
-41% -$2.43M 0.02% 737
2023
Q1 		$5.61M Buy
+643,812
New +$5.15M 0.03% 640
2021
Q1 		– Sell
-195,637
Closed -$1.12M – 1717
2020
Q4 		$1.12M Sell
195,637
-197,275
-50% -$1.49M 0.01% 929
2020
Q3 		$2.85M Buy
+392,912
New +$2.1M 0.02% 603
2020
Q2 		– Sell
-34,525
Closed -$51K – 1569
2020
Q1 		$51K Sell
34,525
-57,334
-62% -$96.3K ﹤0.01% 1042
2019
Q4 		$180K Buy
91,859
+27,468
+43% +$103K ﹤0.01% 1009
2019
Q3 		$330K Buy
+64,391
New +$390K 0.01% 902

Other funds holding CBAY

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.98B AUM 737.95% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return